These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 7525194)

  • 21. [Use of GnGH (GnRH-A) in gynecology].
    Ciardo A; Spina V; Aleandri V
    Minerva Ginecol; 1998; 50(1-2):25-9. PubMed ID: 9577152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical uses of gonadotropin-releasing hormone analogues.
    Casper RF
    CMAJ; 1991 Jan; 144(2):153-8. PubMed ID: 1986827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A clinical control study on the treatment of uterine leiomyoma with gonadotrophin releasing hormone agonist or mifepristone].
    Zeng C; Gu M; Huang H
    Zhonghua Fu Chan Ke Za Zhi; 1998 Aug; 33(8):490-2. PubMed ID: 10806751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GnRH agonists: gonadorelin, leuprolide and nafarelin.
    Pace JN; Miller JL; Rose LI
    Am Fam Physician; 1991 Nov; 44(5):1777-82. PubMed ID: 1835275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gonadotropin-releasing hormone and its analogs.
    Conn PM; Crowley WF
    Annu Rev Med; 1994; 45():391-405. PubMed ID: 8198390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of uterine fibroids with GnRH-analogues prior to hysterectomy.
    Stjernquist M
    Acta Obstet Gynecol Scand Suppl; 1997; 164():94-7. PubMed ID: 9225649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome after depot gonadotrophin-releasing hormone agonist treatment for central precocious puberty: effects on body mass index and final height.
    Traggiai C; Perucchin PP; Zerbini K; Gastaldi R; De Biasio P; Lorini R
    Eur J Endocrinol; 2005 Sep; 153(3):463-4. PubMed ID: 16131610
    [No Abstract]   [Full Text] [Related]  

  • 28. GnRH agonists.
    Schriock ED
    Clin Obstet Gynecol; 1989 Sep; 32(3):550-63. PubMed ID: 2673600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical applications of GnRH agonists in gynaecology.
    Preutthipan S
    J Med Assoc Thai; 1993 Jan; 76 Suppl 1():11-8. PubMed ID: 8113648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gonadotropin releasing hormone agonists and the induction or augmentation of ovulation.
    Martin MC
    J Reprod Med; 1989 Dec; 34(12 Suppl):1034-8. PubMed ID: 2533619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [GnRH-agonists in gynecology I].
    Herrera Suastegui T; Garza Evia AG; Reyes Cuervo H; Alvarado Durán A
    Ginecol Obstet Mex; 1992 May; 60():146-51. PubMed ID: 1618407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gonadotropin-releasing hormone agonists: emerging modification of treatment regimens.
    Hodgen GD
    Curr Opin Obstet Gynecol; 1991 Jun; 3(3):352-7. PubMed ID: 1813003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonistic and agonistic GnRH analogue treatment of precocious puberty: tracking gonadotropin concentrations in urine.
    Roth CL; Brendel L; Rückert C; Hartmann K
    Horm Res; 2005; 63(5):257-62. PubMed ID: 15995342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [GnRH-agonists in gynecology II].
    Herrera Suastegui T; Garza Evia AG; Reyes Cuervo H; Alvarado Durán A
    Ginecol Obstet Mex; 1992 Jun; 60():175-80. PubMed ID: 1618412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contemporary pharmacological manipulation in assisted reproduction.
    Huirne JA; Lambalk CB; van Loenen AC; Schats R; Hompes PG; Fauser BC; Macklon NS
    Drugs; 2004; 64(3):297-322. PubMed ID: 14871171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gonadotrophin-releasing hormone agonist trigger and freeze-all strategy does not prevent severe ovarian hyperstimulation syndrome: a report of three cases.
    Gurbuz AS; Gode F; Ozcimen N; Isik AZ
    Reprod Biomed Online; 2014 Nov; 29(5):541-4. PubMed ID: 25246114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
    Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The programming of IVF cycles with antagonists].
    Hugues JN
    J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S19-20. PubMed ID: 15643680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Indications of GnRH analogues before and after surgery for endometriosis].
    Daraï E; Dubernard G; Azoulay C; Barranger E; Antoine JM; Uzan S
    Gynecol Obstet Fertil; 2005 Dec; 33(12):1014-7. PubMed ID: 16311060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of gonadotropin-releasing hormone-agonists together with other drugs for medical treatment and prevention.
    Schindler AE
    Gynecol Endocrinol; 2009 Dec; 25(12):765-7. PubMed ID: 19905992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.